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Abstract
Persister cells, or superfits, have been strongly implicated in the recalcitrance and recurrence of chronic bacterial infection 
through the dormant (metabolically reduced) phenotype they display and the tolerance to antimicrobial agents this dormancy 
grants them. The complex biochemical events that lead to the formation of persister cells are not completely understood, 
though much research has linked the degradation of type II toxin/antitoxin systems and reduced cellular ATP levels to the 
rise in stress response molecules (where (p)ppGpp is of particular interest), which induce this dormant state. The equally 
complex mechanism of resuscitation is initiated by the cells’ ability to sense nutrient availability via chemotaxis systems. 
Levels of secondary messenger proteins (i.e., cAMP) within the cell are reduced to allow the resuscitation of ribosomes, by 
ribosomal resuscitation factor HflX, to reinstate protein synthesis and, therefore, growth to re-populate. Techniques of superfit 
eradication utilise one, or more, of three approaches (i) direct killing, (ii) re-sensitising persister cells to conventional anti-
microbials, or (iii) prevention of persister formation though few laboratory findings have been translated to clinical practice. 
This work will outline current findings in the field with a critical approach, where possible.
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Introduction
The ability of pathogenic bacteria to survive therapeutic 
intervention is quickly becoming a major medical crisis 
of the modern world, where the emergence of multidrug 
resistance amongst Gram-positive and -negative bacteria 
have rendered conventional antimicrobials inept (Frieri et al. 
2017). Several resistance mechanisms have been recognised 
within bacterial populations including immunosuppression 
of the host, evasion of immune response by the pathogen and 
ineffectiveness of antibiotic therapies (Woudt et al. 2018). 
Persister cells are a survival mechanism exhibited by bac-
teria, during the exponential growth phase, in response to 
a range of adverse environmental conditions (Fisher et al. 
2017). These superfits show tolerance rather than resist-
ance through phenotypic differentiation to the general bac-
terial population; as there are no genotypic variations, the 
replenished post-stress population will display equal sus-
ceptibility to stressors as the original population (Nakouti 
et al. 2017). The role of persister cells has, in recent years, 
gained acknowledgement with regards to the recalcitrance 
and recurrence of bacterial infections, where antimicrobial 
therapy has been implemented (Fisher et al. 2017). The 
focus of this paper is to review research literature published 
around the phenomenon of persister cells, potential models 
for their formation, models for persister resuscitation that 
allows infection to recur and combatant therapies with the 
aim to increase efficacy of treatments targeted towards bac-
terial infections.
From discovery to present day
For many years, the scope of research has been largely directed 
towards the resistance mechanisms of bacteria to antibiot-
ics rather than the innate ability for subpopulation toler-
ance. While working with the still novel penicillin in 1944, 
Joseph Bigger, a medical doctor working in York, concluded 
that penicillin did not have the ability to completely sterilise 
infections (Bigger 1944). Bigger repeatedly observed growth 
following exposure of penicillin to Staphylococcus pyogenes 
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and determined that the surviving cells must be in a “dor-
mant, non-dividing state” being the first to refer to them as 
“persisters” (Bigger 1944). Up until the early 1990s, research 
focused heavily on bacterial resistance, until one Harris Moyed 
addressed persistence due to his interest in the non-heritable 
survival mechanisms of bacteria, which led to the discovery of 
potential models of persister formation (Lewis 2010).
Persister cell dormancy
Persister cells are able to enter a dormant state with drasti-
cally reduced metabolic activity allowing them to survive 
exposure to antimicrobial drugs. Antibiotics rely on a living 
target to exert their bactericidal properties as they perform 
by corrupting the synthesis products of the bacteria, mean-
ing the metabolism of the bacteria is required for effective 
antibiotic function (Kapoor et al. 2017). Dormancy of per-
sisters, in the form of reduced protein synthesis, was evi-
denced by research conducted by Shah et al (2006), where a 
strain of Escherichia coli (E. coli), which expressed Green 
Fluorescent Protein (GFP), was exposed to a β-lactam antibi-
otic (Shah et al. 2006). The strain used expressed GFP under 
control of a ribosomal promoter found only in dividing cells; 
after exposure to the antibiotic some cells appeared very 
faint fluorescence and were tolerant to ofloxacin, proving 
their status as persisters. However, limitations of the method 
were apparent; sorting the cells necessitates dilution of the 
culture into a buffer which changes the concentration and 
medium, therefore, promoting resuscitation of the original 
population from surviving persisters and decreasing persister 
levels (Lewis 2010).
Despite these limitations, when transcriptome analysis 
was performed it revealed a downregulation in biosynthe-
sis genes and an increase in expression of several toxin/ 
antitoxin (TA) genes. The comparison between active gene 
profiles of persister cells and exponentially growing cells 
showed a clear decrease in the synthesis of proteins con-
sistent with energy production and non-essential functions 
(e.g., chemotaxis), indicative of a state of dormancy (Shah 
et al. 2006). Although the dormancy state of persister cells 
has been demonstrated, there is little understanding on the 
mechanisms that occur to activate or promote this dormant 
state of persisters; nor which genes must remain active to 
eventually allow resuscitation of the bacterial population 
(Yamasaki et al. 2020).
Models of persister cell formation
Research into possible models by which persister cell forma-
tion were induced, and the resulting tolerance towards bacte-
ricidal antibiotics, has been increasingly discussed in biofilm 
research over the last decade. The most popular models both 
determine that superfit formation occurs not solely as a result 
of direct exposure to antibiotics but rather as a response to 
common nutrient deficiencies experienced by pathogenic 
bacteria residing inside biofilms; with the added effect of 
conceiving tolerance within persister populations and the 
biofilms that contain them (Defraine et al. 2018).
Type II toxin/antitoxin (TA) systems
TA systems refer to intricately linked genes of two (bicis-
tronic) or more that are responsible for the encoding of a 
toxic protein and its corresponding antitoxin, either a sec-
ondary protein or RNA, which together form a neutral com-
plex (Jankevicius et al. 2016). While the toxic protein is 
stable, the counteracting antitoxin is easily degradable by 
ATP dependent proteases; the toxins are often translation 
inhibitors, down regulating the synthesis of proteins through 
a variety of molecular mechanisms, hence their believed 
involvement in pathogenic bacterial dormancy and tolerance 
of antibiotics (Goormaghtigh et al. 2018).
The first type II TA system identified in vitro and to gain 
notoriety in the formation of persisters in the Gram-negative 
E. coli is the mutant high persistence gene A (hipA) and its 
upstream counterpart hipB, which together form the com-
plex hipBA (Moyed and Bertrand 1983). In the scenario, 
where stress results in hipA levels greater than those of hipB, 
hipA is able to phosphorylate glutamate-tRNA (transfer 
RNA)–ligase (GltX) preventing the transfer of glutamate to 
 tRNAGlu. The accumulation of uncharged  tRNAGlu in the 
ribosomal A site activates the ribosome-associated guano-
sine tetra- and pentaphosphate ((p)ppGpp) synthase, RelA; 
the resulting (p)ppGpp is believed to act as an alarmone 
and trigger the release of toxins from other TA systems 
(Semanjski et al. 2018). These toxins are then able to target 
other protein-encoding genes to downregulate synthesis to 
reduce metabolic activity and enter a state of dormancy. The 
same mutant hipA genes identified in vitro by Moyed in 1983 
were found in patients with recurrent urinary tract infections 
(UTIs). In isolates of Pseudomonas aeruginosa from cystic 
fibrosis patients, and from patients with chronic Candida 
albicans infections further cementing the link between hipA 
and pathogenic recalcitrance (Conlon et al. 2016; LaFleur 
et al. 2006; Mulcahy et al. 2010; Schumacher et al. 2015).
In E. coli, ten other such TA systems have been identi-
fied, the toxins of which all behave as mRNA endonucle-
ases (mRNases) and can be separated into superfamilies 
based on the cleaving point target of the mRNases (Mai-
sonneuve et al. 2011). Six of these mRNases (RelE, YoeB, 
HigB, YhavV, YafO and YafQ) cleave mRNA at the ribo-
somal A site, whereas the other 4 (MazF, ChpB, MqsR and 
HicA) cleave RNA site—specifically and independently of 
the ribosome but all have the effect of downregulating pro-
tein translation (Maisonneuve et al. 2011). Evidence has 
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shown that autoregulation of these TA bicistronic oper-
ons is controlled by the antitoxin, which binds to opera-
tor sequences in the TA promoter region; binding occurs 
more strongly when the antitoxin is in complex with the 
mRNase meaning they themselves behave as co-repressors 
of their own synthesis. However, mRNase in excess of its 
antitoxin disrupts TA complexes and promotes the upregu-
lation of TA operon transcription (Overgaard et al. 2008). 
A proposed explanation for this state is activation of a 
stringent response in exposure to stress, namely, nutrient 
starvation, where a (p)ppGpp pathway involving a Long 
Form Filament (LON)-dependent mechanism leads to the 
degradation of antitoxins (Christensen-Dalsgaard et al. 
2010).
Furthermore, (p)ppGpp of the stringent response is linked 
to the reduction of protein synthesis due it’s interaction with 
RNA polymerase. It is able to directly modulate transcrip-
tion via activation of two key stress responses, the stress 
response for stationary phase (RpoS) and the stress response 
for misfolded proteins (RpoE), which leads to the reduc-
tion in ribosome synthesis (Song and Wood 2020). In addi-
tion to transcriptional modulation, (p)ppGpp stimulates the 
genes responsible for the production of Ribosome Modula-
tion Factor (RMF), hibernation promoting factor (Hpf) and 
ribosome associated inhibitor (RaiA). RMF converts active 
70S ribosomes into inactive 100S ribosomes via an inactive 
90S dimer complex, Hpf converts 90S ribosomes into 100S 
ribosomes and RaiA inactivates 70S ribosomes leading to 
an inability for translation to occur (Song and Wood 2020).
A study performed by Maisonneuve (2011) showed that 
successive deletion of the ten type II TA systems in E.coli 
(known as the Δ10 strain) showed no exponential growth 
deficits, when compared to wild-strain E.coli but resulted 
in the reduction of persister levels following exposure to 
an antibiotic, evidencing their involvement in persistence 
(Maisonneuve et al. 2011). The study also concluded that 
the availability of LON is crucial to the ability of bacterial 
dormancy, as cells presenting LON deletion showed a drastic 
decrease in superfit levels when compared to strains mutated 
to display other protease deficiencies (Maisonneuve et al. 
2011). This explanatory model influenced research for some 
time until the authors of the model discovered considerable 
φ80 phage infection of the original experiment, a “notorious 
laboratory contaminant” which could explain the decrease in 
persister levels and negate their conclusions of TA and LON 
involvement in the formation of persisters (Goormaghtigh 
et al. 2018). In a statement released by the authors of the 
study, it was explained that the claim of mRNase overpro-
duction contributing to bacterial tolerance is still valid but 
that the data collected by the original study could no longer 
be used to support this model. Repeats of the methods in 
an environment free of φ80 phages, showed similar but far 
less conclusive results leaving the mechanism of persister 
formation in Gram-negative species in need of a great deal 
more research (Maisonneuve et al. 2011).
While the link between TA modules and persistence of 
Gram-negative bacteria has been studied, less is known 
about the mechanism of persistence in relation to Gram-
positive populations. Similar deletion of type II TA systems 
in a sample of the Gram-positive S. aureus, as performed on 
the Gram-negative E. coli, showed no effect on the ability of 
superfits to arise (Conlon et al. 2016).
Cellular ATP levels
Bactericidal antibiotics target metabolic pathways to target 
active sites; β-Lactams target peptidoglycan synthesis result-
ing in lysis, aminoglycosides target bacterial ribosomes and 
disrupt translation, and fluoroquinolones prevent re-ligation 
by DNA gyrase and topoisomerase leading to breakages in 
the double strand structure of bacterial DNA (Garneau-
Tsodikova and Labby 2016; Idowu and Schweizer 2017; 
Kapoor et al. 2017). The ability of these pathways to occur 
is crucial for the exponential growth of the population and 
are dependent on ATP; suggesting that a reduction of avail-
able ATP may induce persister formation.
A study by Conlon et al (2013) showed that ATP lev-
els are significantly reduced in the stationary phase of S. 
aureus (Fig. 1); as the metabolic output of exponential 
growth requires larger concentrations of ATP (Conlon et al. 
2013). Stationary phase is where prominent antibiotic toler-
ance similar to that of persisters is observed; suggesting that 
persister formation in S. aureus may be a result of the non-
uniform entering of stationary phase (Conlon et al. 2016). 
Continuing this research in 2016, Conlon et al. found that 
treating growth phase S. aureus with arsenate, which substi-
tutes the phosphate anion during glycolysis inhibiting ATP 
synthesis, to emulate the ATP levels of the stationary phase 
(Fig. 1) increased superfit formation by 325-fold compared 
to wild-type strains and that exposing samples to increased 
ATP levels decreased superfit formation 100-fold (Conlon 
et al. 2016; Kulshrestha et al. 2014). Several stationary phase 
specific promoters were found to have been activated in per-
sisters of the reduced ATP samples (Conlon et al. 2016). 
Activation of these promoters suggests that it is the meta-
bolic differences between the two growth phases imparting 
the ability for antibiotic evasion (Conlon et al. 2016).
Similar results were reported when the effect of cellular 
ATP levels were investigated in Gram-negative E. coli sam-
ples. Using the known persister reporter rrnB P1; which 
sense both (p)ppGpp and ATP; Shan et al (2017) discov-
ered the continued reporting of persisters in both the Δ10TA 
strain and environments lacking (p)ppGpp (Shan et  al. 
2017). With findings consistent to those of the S. aureus 
experiment conducted by Conlon et al (2016), it could be 
proposed that while TA systems are apparent in persister 
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formation, ATP levels play a universal role in the induction 
of persister cells across bacterial species (Conlon et al. 2016; 
Shan et al. 2017).
Persister cell resuscitation
Regardless of the mechanisms which allow cells to enter the 
dormant state and become persisters, one thing is clear, that 
these superfits eventually return to a functional state, where 
the bacterial population is replenished and a relapse of infec-
tion can occur; i.e., the mechanisms that induce dormancy 
are reverted (Svenningsen et al. 2019). The exact process 
by which persister resuscitation occurs is not well known, 
though much research into the topic appears to have been 
conducted by Dr Ryota Yamasaki, and his team, in the recent 
years. His findings around persister cell waking in E. coli 
suggest that the complex process relies on the cell’s ability 
to sense nutrients (Fig. 2) rather than the previously hypoth-
esised stochastic transition between phenotypes (Yamasaki 
et al. 2020).
Nutrient signalling
The proven ability for persister cells to revive in response to 
advantageous environmental changes somewhat negates that 
revival from persister state is a random occurrence (Balaban 
et al. 2004; Kim et al. 2018). A study by Yamasaki et al 
(2020) hypothesised that the presence of single amino acids 
could trigger resuscitation (defined as growth or elongation 
within the sample), initial testing separated four groups of 
five amino acids, E. coli superfits were plated on agar plates 
in which these amino acids were the only carbon source 
and growth was observed after 6 h (Yamasaki et al. 2020). 
The reasoning behind this qualitative assessment method 
being that revived persisters grow at a similar rate to that 
of exponentially growing cells (Kim et al. 2018). Following 
this, individual amino acids were tested in the same manner 
and single cells were assessed using light microscopy; this 
showed alanine (Ala) as the amino acid that promoted the 
highest levels of waking (18 ± 1%, compared to asparagine 
(Asn) with 2 ± 2%); a negative control (agar lacking amino 
acids) showed no waking, proving the role of amino acids in 
persister cell resuscitation (Yamasaki et al. 2020).
Further to this, the study wanted to prove whether Ala 
acts as a true resuscitation signal, rather than simply being 
a carbon and energy source for growth, using an E.coli strain 
that contains an isogenic dadA mutation for inactivation of 
D-amino acid dehydrogenase to prevent growth in the pres-
ence of Ala; the study found that 4% of dadA superfits woke 
in the presence of Ala, whereas no waking was observed in 
the absence of Ala (Franklin and Venables 1976; Yamasaki 
et al. 2020). In addition, Ala was proven to wake superfits of 
the dadA strain even in the presence of a secondary carbon 
and energy source, pyruvate; pyruvate alone did not wake 
any single cells, whereas Ala was able to wake cells to the 
same extent when pyruvate was absent or present meaning 
it must act as a true signal in the resuscitation of persisters 
(Yamasaki et al. 2020).
Chemotaxis systems
Motile bacteria use chemotaxis systems to migrate to envi-
ronments more favourable to growth and survival, the genes 
Fig. 1  ATP levels of S. aureus in stationary and exponential growth 
phases; and in exponential phase following exposure to varying con-
centrations of Arsenate for 15 min. Arsenate forms rapidly hydrolys-
able ADP-As which reduce ATP availability. Stat stationary phase, 
Exp exponential phase, Ars arsenate. (Conlon et al. 2016)
Fig. 2  Suggested model for persister cell resuscitation, whereby the 
availability of nutrients in a post-stress environment promotes the 
return to normal metabolic function. Alanine and glucose are used as 
nutrient saurces (Yamasaki et al. 2020)
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for which are down regulated in the processes that result in 
cell dormancy (Bi and Sourjik 2018; Shah et al. 2006). By 
assessing how individual proteins affected the rate of wak-
ing within the persister population, Yamasaki et al (2020) 
found significant evidence for the role of chemotaxis pro-
teins in persister resuscitation (Yamasaki et al. 2020). Using 
a collection of pCA24N-derived plasmids, for which each 
synthesises one E.coli protein (ASKA collection), persist-
ers were formed and plated on Ala-containing plates with 
chloramphenicol to ensure plasmid retention (Yamasaki 
et al. 2020). After eight days, the largest colonies (i.e., the 
fastest growing) were purified and sequenced to reveal six 
proteins presumed to be stimulators of persister waking; sin-
gle cells containing the ASKA plasmids for these proteins 
were observed on Ala agar gel pads; all six resulted in a rate 
of waking faster than the control containing an empty plas-
mid after an 18 h incubation period, with the greatest wak-
ing occurring in cells producing the chemotaxis response 
regulators CheY and CheA (with 100% and 82% of cells 
waking, respectively)(Yamasaki et al. 2020). In an effort to 
find more evidence, single cells of deletion mutant strains 
ΔCheY and ΔCheA were assessed and showed a complete 
inhibition in their waking; from here, all five of the methyl-
accepting chemotaxis proteins (Tsr, Tar, Trg, Tap, and Aer) 
were investigated using isogenic mutants with Tar and Trg 
showing higher frequencies of waking when in conjunction 
with CheY and CheA (Yamasaki et al. 2020). Hence, the 
conclusion is drawn that persister resuscitation relies on Ala-
nine signalling via the chemotaxis system, more specifically 
via the methyl-accepting chemotaxis proteins Tar and Trg, 
and the chemotaxis regulators CheY and CheA (Yamasaki 
et al. 2020).
Ribosomal resuscitation via rescue proteins
In the formation of persisters, small positively signalling 
molecules regulate factors that, in high concentrations, result 
in the deactivation and hibernation of ribosomes and hence, 
the reduction of product synthesis consistent with dormancy 
(Gohara and Yap 2018). These signal molecules, cAMP and 
supposedly (p)ppGpp, are hypothesised to allow ribosomes 
revival when levels are decreased so that protein synthesis 
may resume (Song and Wood 2020; Yamasaki et al. 2020).
In short, elevated levels of cAMP have been linked to 
increased persistence due their participation in ribosomal 
protein gene regulation, including that of RMF (Shimada 
et al. 2013). Using single cells selected to produce elevated 
levels of cAMP, a clear reduction in rate of waking was 
observed (Yamasaki et al. 2020). Cells were also selected 
to produce the cAMP inhibitor CpdA, the addition of this 
inhibitor saw the rate of waking increase as did exposure 
to the cAMP inhibiting drug atropine with the greatest 
increase observed when both CpdA and atropine were used 
in synergy to decrease cAMP levels (Yamasaki et al. 2020). 
When comparing the ribosome resuscitation factor HflX to 
the ribosome rescue factor ArfB (a negative control as it is 
positively regulated by cAMP), cells producing HflX were 
able to wake much faster than control cells containing an 
empty plasmid and cells producing ArfB showed no waking; 
further, inactivating HflX resulted in the total inhibition of 
waking in single cells, while inactivating ArfB had no effect 
(Yamasaki et al. 2020).
With regards to (p)ppGpp, no discernible mechanism has 
been found to link it to the expression of HflX; however, 
it is known to bind to and inhibit the 100S splitting activ-
ity of HflX so that ribosomes remain in an inactive state 
(Yamasaki et al. 2020). When assessing the waking ability 
of mutated E. coli cells omitting RelA and spoT (a second 
(p)ppGpp synthase) no significant effects towards waking 
were noted; similar finding were reported when the same 
testing was performed on strain of P. aeruginosa, meaning 
(p)ppGpp does not play as large a role in cell resuscitation 
as previously hypothesised (Akiyama et al. 2017; Song and 
Wood 2020).
Combatant therapies
Research into therapies capable of eradicating a persister 
population has provided an extensive list of molecules that 
with further research and development could be approved 
for clinical use; these molecules can be divided into three 
mechanisms of actions, where some molecules may overlap 
these categories, (i) direct killing of metabolically dormant 
persister cells, (ii) sensitising persisters to conventional anti-
biotics by promoting resuscitation and, (iii) compromising of 
molecules linked to the induction of persister cells (Fig. 3) 
(Defraine et al. 2018). It is important to recognise that 
in vivo, pathogenic bacteria often reside within biofilms so 
a difficulty in translating in vitro findings to effective clinical 
therapies is apparent (Wood, 2017).
Direct killing
To directly target persister cells, interventions must utilise 
alternative targets to those of conventional antibiotics; sug-
gested targets include, destruction of bacterial cell mem-
brane, DNA cross-linking, inhibition of key enzymes and 
generation of reactive oxygen species (ROS) (Defraine et al. 
2018). Targeting of bacterial cell walls is a logical approach 
as, despite dormancy, cells require an intact membrane to 
remain viable; both lipoglycopeptides and diarylquinolines, 
among other molecules, have shown promise in their abil-
ity to disrupt the bacterial membranes of persisters across 
multiple species of bacteria (Hurdle et al. 2011). Several 
existing anti-cancer drugs (e.g., Mitomycin C, Cisplatin 
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and Anthracyclines) have been implicated in their ability 
to cross link DNA, even in notoriously difficult to treat spe-
cies, though their high toxicity contraindicates their use in 
treatment (Cruz-Muñiz et al. 2017; Defraine et al. 2018). 
Periodic exposure to the antimicrobials might be required 
as persister cells are often located in the middle of a robust 
biofilm, making access to this particular sub-population 
very difficult. The exact therapy is dependent on bacterial 
kinetics.
Sensitising persister cells
As antibiotic targets involve the corruption of synthesis 
products; one proposed method of exterminating persisters 
is to encourage resuscitation within the dormant population 
so that these targets are actively produced (Defraine et al. 
2018). A number of molecules have been identified with the 
ability to stimulate the metabolism of persisters and cause a 
phenotypic switch from the tolerant dormant type to an anti-
biotic sensitive type (Kim et al. 2011; Pascoe et al. 2014). 
For antibiotics requiring active transport systems to exert 
their bactericidal properties, it has been proven possible to 
manipulate drug influx rates by generating a proton-motive 
force, modifying the membrane pH levels or by inhibiting 
amino acid synthesis to raise energy levels and increase 
uptake (Defraine et al. 2018; Duan et al. 2016). A final pos-
sible approach to sensitising persisters is to use a number 
of mechanistically different antibiotics; research has shown 
that subpopulations exist within a superfit faction that may 
exhibit sensitivity to different antibiotics, the implementa-
tion of existing clinical treatments may work to reduce treat-
ment times as well as costs (Defraine et al. 2018). However, 
exposure to multiple antibiotics could risk promoting drug 
resistance.
Preventing persister formation
The final strategy in combating persister cells lies in prevent-
ing persister formation in the first instance, by interfering 
with mechanisms known to occur in persister formation 
(Defraine et al. 2018). Targeting of the stringent response 
alarmone (p)ppGpp to prevent its accumulation has been 
shown to reduce persister formation across several Gram-
positive species, as has inhibition of the SOS- and oxida-
tive-stress responses (Defraine et al. 2018). Treatment of 
stationary phase cells with nitric oxide (NO) to inhibit 
respiration but prevent protein and RNA degradation pro-
duced populations that resumed growth when exposed to 
more favourable environments without the cells entering a 
state of dormancy; bypassing persister formation resulted in 
cells that remained susceptible to antibiotics, a finding that 
could be critical to preventing chronic infection (Orman and 
Brynildsen 2016). This approach will be particularly effec-
tive in wound healing.
Conclusion
The tolerant behaviours of persister cells are arguably one 
of the most important phenotypes bacteria can possess for 
their survival, though their existence causes great difficulty 
in the treatment of pathogenic infections. Extensive research 
into both the formation and resuscitation of persister cells 
has provided insight into potential points of exploitation so 
as to improve the efficacy of treatment. The lack of consen-
sus surrounding exact models of formation leaves open the 
opportunity for further research, both for E. coli, which has 
been the mainstay species for the majority of research con-
ducted, and other species of bacteria prevalent in infections 
reported by clinicians. A much clearer understanding of the 
occurrences for which resuscitation necessitates is apparent 
when considering the work of Yamasaki et al (2020), whose 
detailed finding have answered many questions posed by the 
existence of persister cells (Yamasaki et al. 2020). A cor-
relation between persisters and the emergence of resistant 
mutations within pathogenic species has also been observed, 
proving them to be a greater threat to modern healthcare 
efforts than may have previously been imagined and making 
Fig. 3  Schematic model for 
combatant persister cell thera-
pies; one branch of treatment 
targets cells prior to persister 
formation, while the remaining 
two branches target existing 
persisters through either direct 
killing or sensitisation to con-
ventional antibiotics by a num-
ber of mechanisms (Defraine 
et al. 2018)
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any research into actionable anti-persister therapies that 
much more crucial (Windels et al. 2019).
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